Invesco Pharmaceuticals E... (PJP)
NYSEArca: PJP
· Real-Time Price · USD
126.15
+0.79 (0.63%)
At close: Aug 17, 2026, 3:59 PM
Invesco Pharmaceuticals ETF (PJP) Stock Price, Analysis & Data
0.63% (1D)
| Bid | n/a |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Beta | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | 23.15 |
| Forward PE | n/a |
| P/B (ttm) | 1.30 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 6,735 |
| Avg. Volume (20D) | 33,401 |
| Open | 125.19 |
| Previous Close | 125.36 |
| Day's Range | 125.38 - 126.53 |
| 52-Week Range | 89.63 - 126.53 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About PJP
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified....
Industry n/a
Sector n/a
IPO Date Jun 23, 2005
Employees n/a
Stock Exchange NYSEArca
Ticker Symbol PJP
Financial Performance
In undefined, Invesco Pharmaceuticals ETF's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.
Financial StatementsPage 1 of 2
